ANGIODYNAMICS INCANGOEarnings & Financial Report
AngioDynamics Inc is a global medical technology firm that designs, manufactures and sells a portfolio of minimally invasive medical devices. Its core offerings cover vascular access, surgical ablation, and oncology care solutions, serving hospitals, outpatient surgery centers and other healthcare providers across North America, Europe and Asia Pacific.
ANGO Q2 FY2026 Key Financial Metrics
Revenue
$79.4M
Gross Profit
$44.8M
Operating Profit
$-6.1M
Net Profit
$-6.3M
Gross Margin
56.4%
Operating Margin
-7.7%
Net Margin
-8.0%
YoY Growth
9.0%
EPS
$-0.15
ANGIODYNAMICS INC Q2 FY2026 Financial Summary
ANGIODYNAMICS INC reported revenue of $79.4M (up 9.0% YoY) for Q2 FY2026, with a net profit of $-6.3M (up 40.9% YoY) (-8.0% margin). Cost of goods sold was $34.6M, operating expenses totaled $50.9M.
Key Financial Metrics
| Total Revenue | $79.4M |
|---|---|
| Net Profit | $-6.3M |
| Gross Margin | 56.4% |
| Operating Margin | -7.7% |
| Report Period | Q2 FY2026 |
Revenue Breakdown
ANGIODYNAMICS INC Q2 FY2026 revenue of $79.4M breaks down across 3 segments, led by Med Device at $37.2M (46.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Med Device | $37.2M | 46.8% |
| Med Tech | $30.4M | 38.3% |
| Other | $11.8M | 14.9% |
ANGIODYNAMICS INC Revenue by Segment — Quarterly Trend
ANGIODYNAMICS INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Med Device and Med Tech) has evolved quarter over quarter.
| Segment | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 |
|---|---|---|---|---|
| Med Device | $37.2M | $35.1M | — | $34.3M |
| Med Tech | $30.4M | $31.4M | — | $27.0M |
| Other | $11.8M | $9.3M | — | $10.7M |
ANGIODYNAMICS INC Annual Revenue by Year
ANGIODYNAMICS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $292.5M).
ANGIODYNAMICS INC Quarterly Revenue & Net Profit History
ANGIODYNAMICS INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $79.4M | +9.0% | $-6.3M | -8.0% |
| Q1 FY2026 | $75.7M | +12.2% | $-10.9M | -14.4% |
| Q4 FY2025 | $80.2M | +12.9% | $-6.0M | -7.5% |
| Q3 FY2025 | $72.0M | -4.2% | $-4.4M | -6.1% |
| Q2 FY2025 | $72.8M | -7.9% | $-10.7M | -14.7% |
| Q1 FY2025 | $67.5M | -14.2% | $-12.8M | -19.0% |
| Q4 FY2024 | $71.0M | -22.1% | $-13.4M | -18.9% |
| Q3 FY2024 | $75.2M | -6.9% | $-187.7M | -249.7% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.2M | $71.0M | $67.5M | $72.8M | $72.0M | $80.2M | $75.7M | $79.4M |
| YoY Growth | -6.9% | -22.1% | -14.2% | -7.9% | -4.2% | 12.9% | 12.2% | 9.0% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $324.8M | $317.7M | $293.6M | $291.6M | $285.4M | $280.1M | $265.6M | $269.7M |
| Liabilities | $106.1M | $112.1M | $97.0M | $104.8M | $99.5M | $97.2M | $86.8M | $93.3M |
| Equity | $218.7M | $205.6M | $196.6M | $186.8M | $185.9M | $183.0M | $178.9M | $176.3M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-12.5M | $5.0M | $-18.3M | $2.5M | $-13.2M | $18.8M | $-15.9M | $4.7M |